“Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy”, FE, vol. 11, no. 2, pp. 91–101, Jun. 2010, doi: 10.7175/fe.v11i2.183.